药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levomenthol
Ferric oxyhydroxide
Ferric oxyhydroxide can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Calcium polycarbophil
Calcium polycarbophil can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Lanthanum III cation
Lanthanum III cation can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Tetraferric tricitrate decahydrate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferric pyrophosphate citrate
Ferric pyrophosphate citrate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferric cation
Ferric cation can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferric sulfate
Ferric sulfate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Calcium gluconate
Calcium gluconate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Calcium citrate
Calcium citrate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Sodium ferric gluconate complex
Sodium ferric gluconate complex can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferric pyrophosphate
Ferric pyrophosphate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Iron sucrose
Iron sucrose can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Ferric carboxymaltose
Ferric carboxymaltose can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Lanthanum carbonate
Lanthanum carbonate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Calcium
Calcium can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Calcium chloride
Calcium chloride can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levomenthol
Iron Dextran
Iron Dextran can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Enprofylline
Inebilizumab
The risk or severity of infection can be increased when Mitoxantrone is combined with Inebilizumab.
Enprofylline
Capmatinib
The serum concentration of Mitoxantrone can be increased when it is combined with Capmatinib.